The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 23, 2024

Filed:

Jun. 10, 2022
Applicant:

Zoll Medical Corporation, Chelmsford, MA (US);

Inventors:

Shane S Volpe, Saltsburg, PA (US);

John D Macho, Farmington, PA (US);

Wade Braden, Glenshaw, PA (US);

Thomas E Kaib, Irwin, PA (US);

Marshal W Linder, New Kensington, PA (US);

Assignee:

ZOLL Medical Corporation, Chelmsford, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/332 (2021.01); A61B 5/00 (2006.01); A61B 5/11 (2006.01); A61N 1/39 (2006.01); A61B 5/282 (2021.01); A61B 5/316 (2021.01); A61B 5/339 (2021.01); A61B 5/349 (2021.01); A61B 5/0205 (2006.01); A61N 1/04 (2006.01);
U.S. Cl.
CPC ...
A61B 5/332 (2021.01); A61B 5/0006 (2013.01); A61B 5/0205 (2013.01); A61B 5/1116 (2013.01); A61B 5/1117 (2013.01); A61B 5/1118 (2013.01); A61B 5/1123 (2013.01); A61B 5/282 (2021.01); A61B 5/316 (2021.01); A61B 5/339 (2021.01); A61B 5/349 (2021.01); A61B 5/4836 (2013.01); A61B 5/6805 (2013.01); A61B 5/7282 (2013.01); A61N 1/046 (2013.01); A61N 1/39 (2013.01); A61N 1/3904 (2017.08); A61N 1/3987 (2013.01); A61B 5/721 (2013.01); A61B 2560/045 (2013.01);
Abstract

A wearable medical device for detecting and treating life-threatening arrhythmias includes a wearable vest portion, sensing electrodes, therapy pads, at least one motion sensor, and a cardiac monitor. The cardiac monitor is configured to detect whether the patient is experiencing a treatable arrhythmia using an ECG signal and in response, determine a confidence level for the detected treatable arrhythmia using outputs from the at least one motion sensor. Determining the confidence level includes detecting patient motion prior to the detection of the treatable arrhythmia. Determining the confidence level further includes increasing the confidence level in response to determining that the patient is motionless coinciding with the detection of the treatable arrhythmia, or decreasing the confidence level in response to determining the patient motion after the detection of the treatable arrhythmia. The cardiac monitor is configured to determine whether to deliver a treatment shock based on the confidence level.


Find Patent Forward Citations

Loading…